MetLife Investment Management’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $110K | Hold |
24,356
| – | – | ﹤0.01% | 2493 |
|
|
2025
Q1 | $113K | Sell |
24,356
-499
| -2% | -$2.32K | ﹤0.01% | 2472 |
|
|
2024
Q4 | $172K | Hold |
24,855
| – | – | ﹤0.01% | 2371 |
|
|
2024
Q3 | $132K | Buy |
+24,855
| New | +$132K | ﹤0.01% | 2509 |
|
|
2024
Q2 | – | Sell |
-11,419
| Closed | -$80.5K | – | 2901 |
|
|
2024
Q1 | $80.5K | Sell |
11,419
-6,738
| -37% | -$47.5K | ﹤0.01% | 2628 |
|
|
2023
Q4 | $103K | Hold |
18,157
| – | – | ﹤0.01% | 2597 |
|
|
2023
Q3 | $87K | Hold |
18,157
| – | – | ﹤0.01% | 2647 |
|
|
2023
Q2 | $124K | Hold |
18,157
| – | – | ﹤0.01% | 2553 |
|
|
2023
Q1 | $141K | Hold |
18,157
| – | – | ﹤0.01% | 2404 |
|
|
2022
Q4 | $138K | Hold |
18,157
| – | – | ﹤0.01% | 2451 |
|
|
2022
Q3 | $148K | Hold |
18,157
| – | – | ﹤0.01% | 2469 |
|
|
2022
Q2 | $176K | Hold |
18,157
| – | – | ﹤0.01% | 2408 |
|
|
2022
Q1 | $255K | Buy |
+18,157
| New | +$255K | ﹤0.01% | 2205 |
|
|
2021
Q4 | – | Sell |
-4,756
| Closed | -$106K | – | 2521 |
|
|
2021
Q3 | $106K | Buy |
+4,756
| New | +$106K | ﹤0.01% | 2423 |
|